🔍 Description:

PE 22-28 is a synthetic peptide derived from the naturally occurring neuropeptide substance P. It has been studied for its neuroprotective properties and its potential role in treating neurological disorders. PE 22-28 appears to interact with the neurokinin-1 (NK1) receptor, which is involved in the regulation of mood, anxiety, and stress responses.

💪 Health Benefits:

– Neuroprotection: PE 22-28 has demonstrated potential neuroprotective effects, which may help protect neurons from damage and support overall brain health. This makes it a candidate for treating neurodegenerative diseases.

– Cognitive Enhancement: Preliminary studies suggest that PE 22-28 may enhance cognitive functions such as learning and memory. It is thought to exert these effects by modulating neurotransmitter systems in the brain.

– Antidepressant Effects: Research indicates that PE 22-28 may have antidepressant properties, potentially providing relief from depressive symptoms by influencing the NK1 receptor pathway.

– Anti-Anxiety Properties: PE 22-28 may also exhibit anxiolytic (anti-anxiety) effects, helping to reduce anxiety levels and improve stress resilience.

💉 Dosing/Administration:

– Dosing: The specific dosing regimen for PE 22-28 is not well-established as there are no published trials/studies done on humans. One doctor who claims to have had success using PE 22-28 on patients suffering from major depressive disorder stated that administering 400 mcg intranasally once daily showed improvement in cognition and presented no lethargy.

⚠️ Side Effects and Safety:

– Safety Profile: The safety profile of PE 22-28 is still under investigation. As with any experimental peptide, its use should be under the supervision of healthcare professionals in a controlled research environment. Its clinical efficacy and safety require further research.